Please login to the form below

meningitis

This page shows the latest meningitis news and features for those working in and with pharma, biotech and healthcare.

MSD’s Vaxneuvance approved by MHRA for prevention of pneumococcal diseases in children

Invasive pneumococcal disease can cause serious and potentially life-threatening infections, including pneumonia and meningitis, and has been on the rise among infants and children.

Latest news

WHO publishes first position paper on optimising brain health

The paper also emphasised the morbidity and mortality caused by neurological disorders worldwide as neurological disorders led by stroke, migraines, dementia and meningitis are currently the number one cause of disability
WHO launches funding appeal for greater Horn of Africa prompted by food crisis

WHO has reported outbreaks of measles in six of the seven countries, against a background of low vaccination coverage, and countries fighting both cholera and meningitis outbreaks, as hygiene conditions worsen
GSK beats expectations thanks to strong vaccine sales in Q2

GSK's vaccine business was up by 39% to £1.6bn thanks to the strong growth (46%) of its meningitis vaccine. ... The boost came from strong sales of its vaccine business, which was up 39% to £1.6bn thanks to the strong growth (46%) of its meningitis
Pfizer to evaluate its pneumococcal vaccine alongside COVID-19 booster jab

In addition, 20vPnC also contains capsular polysaccharide conjugates for a further seven serotypes that cause invasive pneumococcal disease and have been associated with high case-fatality rates, antibiotic resistance and meningitis.
AZ/Oxford University’s COVID-19 vaccine to be evaluated in children and young adults

given a control meningitis vaccine.

More from news
Approximately 15 fully matching, plus 65 partially matching documents found.

Latest Intelligence

Innovation and digital health comms recognised at Communiqué Awards

The work was centred around an awareness campaign on meningococcal meningitis, and the need for vaccination, targeting 15-24-year olds – the second highest at-risk group in the UK. ... In a campaign first, Pfizer granted full creative licence to ten
Re-awakening the emotion in healthcare communications

One example is the Teddy Bears’ Picnic on the banks of the river Thames near Tower Bridge, which aimed to raise awareness of bacterial meningitis.
Pharma deals in June 2015

When GSK acquired two additional rival meningitis vaccines from Novartis, namely Menveo and Bexsero, the European Commission and other antitrust regulators were concerned that this gave GSK too much power in ... As a result GSK has sold two of its own
Pharma deals during July 2014

The transaction includes two vaccines currently marketed outside the US and primarily in Europe: NeisVac-C, a vaccine against group C meningococcal meningitis (MenC), and FSME-IMMUN against tick-borne encephalitis
Pharma deals during April 2014

franchise. The icing on the cake is Bexsero for the prevention of meningitis B, which has EU approval and orphan drug designation in the US. ... Also included in the meningitis “goodie bag” is the late-stage combo candidate MenABCWY.

More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.

Latest appointments

McCann Health London bolsters creative leadership team

Before joining the London team, he worked on the launch of national and international campaigns, including a meningitis awareness campaign that has almost 50 million views on YouTube.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

UK vs US: what makes a successful immunisation programme?

The Meningitis B vaccine is unique to the UK and since we live in the UK that was easy to get.
Power to the People: Why consultation is key for improved patient outcomes

Meningitis Research Foundation has been working with Say Communications to help boost our public consultation on a Roadmap to Defeat Meningitis. ... Our roadmap. When it comes to developing a Roadmap to Defeat Meningitis, Meningitis Research Foundation
Say Communications

Meningitis Research Foundation has been working with Say Communications to help boost our public consultation on a Roadmap to Defeat Meningitis.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Senior Medical Writer: Highly competitive salary

Associate Director - Global Healthcare Consulting: £100,000 - £115,000 yearly

Omnichannel Account Director: £55,000 - £65,000 yearly

Pharmacovigilance Project Lead: Highly competitive salary

Strategy Director - Healthcare Advertising: £90,000 - £120,000 yearly

Technical Sales Representative: Highly competitive salary

Pharmacovigilance Manager: Highly competitive salary

Early Access Program - Regulatory Affairs (EAP-RA): Highly competitive salary

PMHub

Add my company

IPG Health Medical Communications

We are the world's most celebrated and awarded Medical Communications agencies. We are 800 experts obsessed with combining science, creativity...

Latest intelligence

The speed of science and the pace of comms: Pharma red tape slows comms but there is a solution, Paul Hutchings, founder of fox&cat, writes....
Improving cardiovascular disease care and awareness: Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
Virtual Patient Engagement Program: A Customer Story: Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......

Email:
Password:

Please login to the form below

meningitis

Subscribe to our email news alerts

Quick links